Viewing Study NCT00234403


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2025-12-30 @ 2:58 AM
Study NCT ID: NCT00234403
Status: COMPLETED
Last Update Posted: 2009-04-23
First Post: 2005-10-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module